Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 177189

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : December | Volume : 17 | Issue : 12 | Page : EC07 - EC10 Full Version

Factors Affecting Blood Donations among COVID-19 Plasma Donors at a Tertiary Care Hospital in Mandya, Karnataka, India


Published: December 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/63291.18821
P Yogendra, MU Mythreyi, BG Malathi, Ayshath Shumaisa

1. Assistant Professor, Department of Pathology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India. 2. Assistant Professor, Department of Pathology, Rajarajeshwari Medical College, Bangalore, Karnataka, India. 3. Associate Professor, Department of Pathology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India. 4. Postgraduate Student, Department of Pathology, Mandya Institute of Medical Sciences, Mandya, Karnataka, India.

Correspondence Address :
Dr. MU Mythreyi,
#103, Siri Elegance, 11th Main Road, Uttarahalli, Bangalore-560061, Karnataka, India.
E-mail: m.u.mythreyi76@gmail.com

Abstract

Introduction: Blood group antibodies are associated with susceptibility to Coronavirus Disease 2019 (COVID-19) infection among different blood groups. Factors such as age and male sex have been identified as risk factors for COVID-19 and disease severity.

Aim: Determination of blood groups of COVID-19 positive plasma donors and examine the association of blood groups with different sexes and age groups. Additionally, the study aims to investigate the factors that either prevent or motivate COVID-19 positive individuals to donate plasma.

Materials and Methods: This retrospective cross-sectional study analysed records from July 2020 to June 2021 at the Blood Bank of Mandya Institute of Medical Sciences, Mandya, Karnataka, India. The sample size included 115 COVID-19 plasma donors, selected using inclusion and exclusion criteria. Data on blood group, age, sex, and factors influencing plasma donation were recorded. The collected data was entered into a Microsoft Excel sheet and analysed using Statistical Package for Social Sciences (SPSS) version 20.0 statistical software, applying the Chi-square test.

Results: Among the 115 COVID-19 positive patients, 113 were males and two were females. The most commonly affected age group was between 31-40 years (44 donors), and the most commonly observed blood group was O+ve (44 cases). There was no significant association between gender and age group (p-value-0.299). Similarly, there was no significant association between blood group and age groups (p-value-0.730). When evaluating the reasons for donating blood, the majority of people (33 out of 115) mentioned that their family member required blood. The provision of transport facilities by the blood bank did not significantly increase the number of blood donations, as most people preferred using their own vehicles (44 out of 115) due to the fear of COVID-19 infection. Among their friends, the main reason for not donating blood was the fear of infection (63 out of 115).

Conclusion: Individual with blood group ‘O’ were more affected by COVID-19 compared to other blood groups. The pandemic has impacted blood transfusion services as fewer donors are visiting hospitals for blood donation. It is important to thoroughly assess and address the various reasons that prevent individuals from donating plasma through mass awareness campaigns.

Keywords

Blood bank, Blood transfusion, Coronavirus disease 2019

The spread of the coronavirus has strained healthcare and testing resources, making it difficult to identify and prioritise individuals at risk. The COVID-19 virus attaches to the human Angiotensin-Converting Enzyme 2 (ACE-2) receptor receptor through the spike protein, facilitating cell infection. Additionally, the COVID-19 virus acts as a receptor and/or co-receptor for blood group antigens (1). Studies have shown that factors such as age, male sex, and non communicable diseases like cardiovascular disease, diabetes, and Chronic Obstructive Pulmonary Disease (COPD) increase the risk of COVID-19 infection and severity (2).

Blood types are inherited, and certain environmental factors can influence the inheritance of blood types in subsequent generations (3). ABO blood groups have been associated with infectious diseases (2). Previous studies have indicated that individuals with blood group ‘O’ are more susceptible to Norwalk virus and Helicobacter pylori infection (2). Anti-A antibodies inhibit the adhesion of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) protein-expressing cells to ACE-2-expressing cell lines, making individuals with certain blood groups more susceptible to COVID-19 infection (3). Numerous studies have demonstrated that individuals with blood group ‘A’ are more affected by COVID-19 compared to other blood groups (1),(2). In South India, the ‘O’ blood group is predominant and has been found to be affected, as shown in studies conducted by Das PK et al., and Periyavan S et al., (4),(5).

The pandemic has impacted blood transfusion services due to a decrease in the number of donors visiting hospitals for blood donation. Inadequate communication from public health departments and the circulation of false information on social media have contributed to fear among the general population.

It is crucial to identify factors that either prevent or motivate blood donors. This may be due to doubts and misinformation about blood donation. The aim of this study is to describe the blood groups of COVID-19 positive plasma donors and investigate the association between different blood groups and sexes, as well as different age groups. Additionally, the study aims to identify factors that either prevent or motivate COVID-19 positive plasma donors to donate plasma.

Material and Methods

The current retrospective cross-sectional study was conducted at the Blood Bank, Mandya Institute of Medical Sciences, Mandya, Karnataka, India. Records from July 2020 to June 2021 were reviewed during July 2022 to August 2022. Ethical clearance was obtained with Institutional Ethics Committee (IEC) number- MIMS/IEC/584. Data were collected from the records maintained at the blood bank and through a questionnaire prepared by the authors [Annexure-1] to assess information about blood donation during the lockdown period.

Inclusion criteria: Records entered in the COVID-19 plasma donor register who passed all the screening tests during the study period. The screening tests followed the ICMR criteria, which included male and non pregnant female donors who were 14 days post-COVID-19 infection, with a positive COVID-19 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) or Rapid Antigen Test (RAT) report, and an ELISA IgG antibody titre against COVID-19 (1:640). Other inclusion criteria involved an age between 18-60 years, weight >50 kg, haemoglobin >12.5 g/dL, and being negative for HIV, Hepatitis B, Hepatitis C, Syphilis, and Malaria (6).

Exclusion criteria: Insufficient donor data and repeated data from the same donor were excluded from the study.

The sample size consisted of 115 COVID-19 plasma donors who donated plasma atleast 14 days after infection. Details such as blood group, age, sex, and factors influencing plasma donation were recorded.

Statistical Analysis

The collected data was recorded in a Microsoft Excel sheet and will be analysed using SPSS 20 statistical software. Descriptive statistics, including mean, standard deviation, and percentage, was utilised for inferential statistics. The Chi-square test was applied to examine associations, and the t-test to compare means. A significance level of 5% (p<0.05) is considered significant.

Results

Among the 115 COVID-19 positive patients, 113 were males and 2 were females. The most commonly affected age group was between 31-40 years, with 44 donors, followed by the age groups of 21-30 years (41 donors), 41-50 years (24 donors), and 51-60 years (6 donors). The most commonly affected blood group was O+ve, accounting for 44 cases, followed by B+ve with 33 cases and A+ve with 28 cases. There were 4 cases of AB+ve blood group, 3 cases of A-ve blood group, and 1 case each of B-ve, O-ve, and AB-ve blood groups (Table/Fig 1).

The association between blood group and age groups was assessed using the Chi-square test, with a Chi-square value of 16.674. The p-value was not found to be significant (p-value=0.730).

When assessing the reasons for donating blood, it was found that the majority of people (33 out of 115) mentioned that they donated blood when their family member or friend required it. This was followed by the reason of donating when a patient’s relative requested it (30 out of 115). Other reasons included being appealed by a public figure or celebrity (27 out of 115), social media campaigns for blood donation (14 out of 115), and NGOs working for blood donation contacting them (11 out of 115).

An evaluation was conducted to determine whether providing transport facilities by the blood bank improved the number of blood donations during the COVID-19 pandemic, considering the non availability of transport. The majority of people (44 out of 115) preferred to use their own vehicles to reach the blood bank due to the fear of catching a COVID-19 infection. This was followed by the reason that many individuals felt encouraged to donate blood (39 out of 115) if transport was provided by the blood bank. A few people (27 out of 115) were unsure about donating blood even after transport arrangements were made to the blood bank. Only a small number of people (5 out of 115) felt that their decision to donate blood would not change even if transport was arranged to the blood bank (Table/Fig 2).

An assessment was conducted on the reasons for friends not donating blood. The majority of people (63 out of 115) cited the fear of infection as the reason. This was followed by travel restrictions due to the lockdown (42 out of 115). A few individuals (6 out of 115) mentioned a lack of motivation as the reason, and a very small number of people (4 out of 115) cited financial crisis as the reason.

Discussion

This study aimed to investigate if any particular blood group was more prone to COVID-19 infection. During the first wave of COVID-19, plasma therapy was used as a treatment post-infection, and the study aimed to assess the factors affecting plasma donation, including concerns about exposure to infection and the unavailability of transport due to the lockdown. In present study, males were more affected compared to females. A study by Vahidy FS et al., found a higher SARS Co-V positivity rate in males compared to females, with an odds ratio of 1.20 (7). Another study by Venkatraja B et al., conducted in Mysuru showed a higher incidence of infection in males compared to females, with a male to female ratio of 1:0.59. The Mann-Whitney U test value was significant with a p-value of U critical-0.012 (8).

In present study, the age group between 31-40 years was most commonly affected. A study by Monod M et al., showed that the age group between 20-49 years was affected by COVID-19 (9). The study by Garg I et al., categorised patients into three groups: severely infected, moderately infected, and mildly infected with COVID-19. In the severely infected group, 82% of the subjects were above 45 years of age, in the moderately infected group, 77% were above 45 years of age, and in the mildly infected group, only 46% were above the age of 45 years (10). A study by Darshan MS, found that 94.8% of 730 cases were above 40 years of age and had severe manifestations of COVID-19 (11). Data released by the Center for Disease Control and Prevention showed that the most commonly affected age group was between 18-29 years of age (12).

In present study, the most commonly affected blood group was O+ve, accounting for 44 cases, compared to A+ve blood group, which accounted for 28 cases. Few studies have been conducted to assess the association between blood group and COVID-19 infection. A study by Padhi S et al., in Karnataka showed that group O cases accounted for 39% of COVID-positive cases, followed by group A (24.57%), group B (29.63%), and group AB (5.83%) (13). Another study by Das PK et al., found that the most common blood group among blood donors in South India is O (38.75%), followed by B (32.69%), A (18.85%), and AB (5.57%) (4). A study by Periyavan S et al., in Bangalore showed that the majority of donors belonged to the O group (39.81%), followed by B (29.95%), A (23.85%), and AB (6.37%) groups, following the Asiatic trend of O>B>A>AB (5). According to the blood bank statistics of Mandya Institute of Medical Sciences, the most common blood group among donors was O (4918 O positive donors and 251 O negative donors out of a total of 12010 donors in 2022). All these pieces of evidence support present study finding that the O group is the most commonly affected in COVID-19 infection.

In a study conducted by Yanardag D and Bankir M, it was found that the prevalence of COVID-19 was higher in blood group A, followed by blood groups B, AB, and O (1). A meta-analytic study by Pourali F et al., found that the frequency of blood group A was higher among COVID-19 infected individuals, ranging from 28.77-44.44%, while the frequency of blood group O among COVID-19 infected individuals ranged from 18.18-45.75% (2). Another study by Zhao J et al., demonstrated that individuals with blood group A had a higher risk, while those with blood group O had a lower risk of acquiring COVID-19. Among 1775 COVID patients from Wuhan Jinyintan hospital, the distribution of blood groups was as follows: 37.75% for group A, 26.42% for group B, 10.03% for group AB, and 25.80% for group O. The proportion of group A in COVID-19 patients was 37.75%, compared to 32.16% in the normal subjects. Additionally, the study found that age and gender had less influence on the ABO blood group distribution in the patients (3).

The association of gender with respect to age groups was assessed using the Chi-square test with a Chi-square value of 3.673. The p-value was not found to be significant (p-value=0.299). This finding was consistent with a study conducted by Al-Akkam KA et al., which also found non significant associations between COVID-19 symptoms and patient’s gender (p value=0.911) and age (p-value=0.989) (14).

The association of blood group with respect to age groups was assessed using the Chi-square test, with a Chi-square value of 16.674. The p-value was not found to be significant (p-value=0.730). In a study conducted by Zhao J et al., it was found that the influence of age group on blood group distribution did not have a significant effect (3).

Fear of infection and lack of transport were the main reasons for not donating plasma during the COVID-19 pandemic. The questionnaire used to assess the reasons for donating blood during this time yielded the following responses: 33 respondents mentioned a close family member requiring blood, 30 respondents mentioned a patient’s relative requesting them to donate, 27 respondents mentioned motivation by a public figure or celebrity, 14 respondents mentioned social media propaganda for donation, and 11 respondents mentioned NGOs working for blood donation contacting them.

A descriptive cross-sectional study conducted by Tripathi PP et al., concluded that the fear of contracting COVID-19 and decreased motivation among blood donors were major hurdles to blood donation activity. Among the 503 donors surveyed, 57.1% expressed fear of COVID-19 infection, with 2.5% exhibiting extreme fear. According to the study, the blood donation area environment and the travelling to the blood donation centre were identified as major sources of potential COVID-19 infection among participants. The most influential factors motivating blood donation were requests from patients (30%), followed by the need for blood from family or friends and social media motivation (both at 26%) (15).

Due to the significant impact of transport availability during the COVID-19 pandemic, a question in present study is included to assess whether the non availability of transport was a reason for not donating blood. The question asked was: “If pick-up and drop facility were provided by the blood bank, what difference would it make in donating blood?” The major responses we received were as follows: 44 respondents preferred using their own vehicle, indicating that the fear of infection was the primary factor preventing them from donating blood. Thirty nine respondents stated that they would be willing to donate blood if transport was arranged. Twenty seven respondents were unsure about the effect of transport on their decision, and the least number of responses (5) indicated that transport arrangements would not affect their decision to donate blood.

Present study findings revealed that the main reason for not donating blood during the COVID-19 pandemic was the fear of infection (63 responses), followed by travel restrictions (42 responses), lack of motivation (6 responses), and financial crisis (4 responses). A study conducted by Sachdev S et al., found that more than half of the participants (415 out of 749) reported a fear of infection (16). Similarly, a descriptive cross-sectional study by Tripathi PP et al., concluded that the fear of catching COVID-19 infection and decreased motivation among blood donors were significant deterrents to blood donation activity (15).

Limitation(s)

Parameters such as a history of cardiovascular disease, diabetes, and COPD to assess their association with COVID-19 infection was not included.

Conclusion

The study did not find any association between blood group and COVID-19 infection, as well as between gender and age group in relation to COVID-19 infection. The main factor that prevented individuals from donating blood, even when transport was provided, was the fear of catching the infection.

References

1.
Yanardag D, Bankir M. Relationship of SARS-CoV-2 pandemic with blood groups. Transfus Med Hemother. 2021;48(3):161-67. [crossref][PubMed]
2.
Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: A live meta-analysis. New Microbes New Infect. 2020;37:100743. [crossref][PubMed]
3.
Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Jul Clin Infect Dis. 2021;73(2):328-31. [crossref][PubMed]
4.
Das PK, Nair SC, Harris VK, Rose D, Mammen JJ, Bose YN, et al. Distribution of ABO and Rh-D blood groups among blood donors in a tertiary care centre in South India. Tropical Doctor. 2001;31(1):47-48. [crossref][PubMed]
5.
Periyavan S, Sangeetha S, Marimuthu P, Manjunath B, Seema D. Distribution of ABO and Rhesus-D blood groups in and around Bangalore. Asian J Transfus Sci. 2010;4(1):41. [crossref][PubMed]
6.
Evidence based advisory to address inappropriate use of convalescent plasma in COVID-19 patients. Indian Council of Medical Research. 2020 Nov 17. [https://www.icmr.gov.in/pdf/covid/techdoc/ICMR_ADVISORY_Convalescent_ plasma_17112020_v1.pdf].
7.
Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PloS One. 2021;16(1):e0245556. [crossref][PubMed]
8.
Venkatraja B, Srilakshminarayana G, Kumar BK, Hegde MN, Kanchan J, Karuvaje G, et al. Preliminary evidence from a cross-sectional study on epidemiology and early transmission dynamics of COVID-19 in Karnataka State of India. Journal of Health and Allied Sciences NU. 2021;11(03):178-87. [crossref]
9.
Monod M, Blenkinsop A, Xi X, Hebert D, Bershan S, Tietze S, et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science. 2021;371(6536):eabe8372. [crossref][PubMed]
10.
Garg I, Srivastava S, Dogra V, Bargotya M, Bhattar S, Gupta U, et al. Potential association of COVID-19 and ABO blood group: An Indian study. Microb Pathog. 2021;158:105008. [crossref][PubMed]
11.
Darshan MS. Descriptive study on the distribution of ABO blood group and Rh type in the mechanically ventilated patients with COVID-19 disease. Eur J Mol Clin Med. 2022;9(2):1803-10.
12.
CDC- National Center for Health Statistics-Homepage. https://www.cdc.gov/ nchs/.Nov 8,2022.
13.
Padhi S, Suvankar S, Dash D, Panda VK, Pati A, Panigrahi J, et al. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. Transfus Clin Biol. 2020;27(4):253-58. [crossref][PubMed]
14.
Al-Akkam KA, Abdul-Husseein MK, Abdul-Husseein HK, Bash HS. Assessing the possible impact of patient’s demographic data oncoronavirus symptoms. ArchivosVenezolanos de Farmacología y Terapéutica. 2021;40(8):806-10.
15.
Tripathi PP, Kumawat V, Patidar GK. Donor’s perspectives on blood donation during COVID-19 pandemic. Indian J Hematol Blood Transfus. 2022;38(3):536-45. [crossref][PubMed]
16.
Sachdev S, Kishore K, Singh L, Lamba DS, Hans R, Dhawan HK, et al. Exploration of COVID-19 related fears deterring from blood donation in India. ISBT Sci Ser. 2021;16(2):147-57.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/63291.18821

Date of Submission: Feb 05, 2023
Date of Peer Review: Apr 15, 2023
Date of Acceptance: Nov 06, 2023
Date of Publishing: Dec 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Feb 08, 2023
• Manual Googling: May 19, 2023
• iThenticate Software: Nov 03, 2023 (13%)

ETYMOLOGY: Author Origin

EMENDATIONS: 10

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com